Aptinyx Receives NIH Grants for Neurologic Disorders Treatment R&D
Aptinyx has received three grants worth potentially $2.85 million from the National Institutes of Health to research and develop new therapeutic compounds for neuropathic pain and age-related cognitive decline. The NIH’s National Institute of Neurological Disorders and Stroke awarded Aptinyx a one-year, $1.25 million grant to fund the development of compounds for neuropathic pain treatment, the biopharmaceutical company said Thursday. […] More